Intranasal Fentanyl

Intranasal Fentanyl is a pharmaceutical formulation of the synthetic opioid fentanyl administered via the nasal route, distinguished by its rapid absorption through the nasal mucosa to provide fast-acting analgesia for the management of breakthrough cancer pain.

169

Publications

7.5K

Citations

749

Authors

315

Institutions

Publications per year

2017–2026

43

Publications

169

Authors

749

  1. LP
    Lars Popper

    Norwegian University of Science and Technology, Norway

    6 publications · 339 citations

    6

    h-index

  2. ML
    Meredith L Borland

    Princess Margaret Hospital for Children, Australia

    6 publications · 711 citations

    6

    h-index

  3. FE
    Franz E Babl

    Royal Children's Hospital, Australia

    4 publications · 149 citations

    4

    h-index

  4. PM
    Paul M Middleton

    UNSW Sydney, Australia

    4 publications · 255 citations

    4

    h-index

  5. SM
    Sebastiano Mercadante

    La Maddalena, Italy

    4 publications · 257 citations

    4

    h-index

1–5 of 749

Venues

  1. The American Journal of Emergency Medicine

    AJEM · 10 publications · 422 citations

    10

    h-index

  2. Prehospital Emergency Care

    7 publications · 315 citations

    7

    h-index

  3. Pediatric Emergency Care

    5 publications · 120 citations

    5

    h-index

  4. Anesthesia & Analgesia

    5 publications · 327 citations

    5

    h-index

  5. Clinical Therapeutics

    5 publications · 330 citations

    5

    h-index

1–5